StreetInsider.com News Articles

Immutep receives A$856,669 R&D tax rebate from Australia

Wed, 30 Sep 2026 08:04:46 -0400

Immutep Limited (NASDAQ: IMMP) received an A$856,669 cash rebate from the Australian Federal Government's R&D tax incentive program, the company announced. The rebate relates to eligible R&D expenditure incurred during the 2025 fiscal year.

The payment followed approval from AusIndustry of Immutep's application for an Advance overseas finding, which allowed certain overseas R&D activities to qualify for the incentive alongside the company's eligible Australian activities.

Immutep also receives the French CIR tax incentive through its subsidiary Immutep S.A.S. for eligible R&D activities conducted in the European Union. The company's German subsidiary, Immutep GmbH, received its first payment under Germany's Forschungszulage R&D tax

Immutep Receives ~A$0.86 Million R&D Tax Incentive

Wed, 30 Sep 2026 08:00:00 -0400

SYDNEY, AUSTRALIA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces that it received an A$856,669 cash rebate from the Australian Federal Government’s R&D tax incentive program. The cash rebate was provided in respect of expenditure incurred on eligible R&D activities conducted in the 2025 fiscal year.

This follows approval from AusIndustry of Immutep’s application for an Advance overseas finding. Due to the Advance overseas finding, certain of Immutep’s overseas research and development

Immutep Receives ~A$0.86 Million R&D Tax Incentive

Wed, 30 Sep 2026 08:00:00 -0400

This follows approval from AusIndustry of Immutep’s application for an Advance overseas finding. Due to the Advance overseas finding, certain of Immutep’s overseas research and development

Form 6-K IMMUTEP Ltd For: Sep 21

Tue, 22 Sep 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260922/27087101.html

Form 6-K IMMUTEP Ltd For: Sep 11

Fri, 11 Sep 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260911/27053683.html

Form 424B3 Immutep Limited/ADR

Thu, 10 Sep 2026 10:05:00 -0400

si-local-file:///var/storage/secattach/20260910/27046638.html

Form 6-K IMMUTEP Ltd For: Jul 30

Mon, 03 Aug 2026 06:06:00 -0400

si-local-file:///var/storage/secattach/20260803/26853143.html

Form 6-K IMMUTEP Ltd For: Jul 30

Mon, 03 Aug 2026 06:06:00 -0400

si-local-file:///var/storage/secattach/20260803/26853143.html

Form 6-K IMMUTEP Ltd For: Jul 30

Mon, 03 Aug 2026 06:06:00 -0400

si-local-file:///var/storage/secattach/20260803/26853143.html

Form 6-K IMMUTEP Ltd For: Jul 13

Tue, 14 Jul 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260714/26764188.html

Form 6-K IMMUTEP Ltd For: Jul 13

Tue, 14 Jul 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260714/26764188.html

Form 6-K IMMUTEP Ltd For: Jul 13

Tue, 14 Jul 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260714/26764188.html

Immutep Limited (IMMP) Reiterated at Market Perform by Citizens on Phase 1 Data

Tue, 14 Jul 2026 04:12:03 -0400

Citizens analyst Reni Benjamin reiterated a Market Perform rating on Immutep Limited (NASDAQ: IMMP).

The analyst commented, "We maintain our Market Perform rating for Immutep, based on a cash per share analysis. Yesterday, Immutep reported updated data from an investigator-initiated Phase 1 study showcasing an impressive mOS of 30.9 months in 51 1L NSCLC patients. We view these data as promising, and yet another piece of evidence that the Phase 3 TACTI-004 futility analysis failure is likely due to some other issue rather than biologic. With the root cause analysis of the TACTI-004 trial underway, meaningful progress on IMP761 in AID,

Form 6-K IMMUTEP Ltd For: Jun 04

Fri, 05 Jun 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260605/26607940.html

Form 6-K IMMUTEP Ltd For: Jun 04

Fri, 05 Jun 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260605/26607940.html

Form 6-K IMMUTEP Ltd For: Jun 04

Fri, 05 Jun 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260605/26607940.html

SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP

Thu, 28 May 2026 09:00:00 -0400